Facilitated by the Penn Center for Innovation, the Gene Therapy Program, under the direction of James Wilson, MD, PhD, has formed a manufacturing partnership with Wuxi AppTec Inc. to open a 145,000-square-foot cell and gene therapy manufacturing plant at the Philadelphia Navy Yard Corporate Center next year, the Philadelphia Business Journal reports. "Advances in the technology of gene transfer developed at the University of Pennsylvania have ushered in an era of exciting translational research in gene therapy," said Dr. Wilson to the Journal.